Blog

Neopharm Labs Acquires Averica Discovery

  Today Averica Discovery announced its acquisition by Neopharm Labs, an analytical testing lab based out of Quebec. Together the companies offer a full range of services that cover every stage of the drug development cycle including R&D, method development and validation, impurity isolation and profiling, stability testing and management, and commercial testing in chemistry and microbiology. Excerpt from Press Release – “Our clients can now take advantage of an expanded range of services,” adds Dr. Jeffrey Kiplinger, President and …

Continue reading

Journal of Chromatography – New Issue on Enantioseparations

Shout out for the new issue of the Journal of Chromatography – it’s on chiral chromatography!  Available wherever such products are sold (the Harvard Coop?)… or on the interwebs, of course. First papers I read : Preparative supercritical fluid chromatography: A powerful tool for chiral separations   David Speybrouck, Emmanuelle Lipka Comparison of liquid and supercritical fluid chromatography mobile phases for enantioselective separations on polysaccharide stationary phases  Syame Khater, Marie-Anne Lozac’h, Isabelle Adam, Eric Francotte, Caroline West Toward structure-based predictive tools for the …

Continue reading

Averica Answers: Can You Capture a 0.01% Impurity?

Averica Answers is a series of short videos that each tackle a question we are often asked. In this video, Paul Lefebvre discusses trace impurity isolation. We do like to work with the customer to define a source of enriched material. Once we define that source of material it becomes easy to work with.  Now to say, if we had to work with something that was at a very low level, that means is it’s detectable.  Because it’s separatable, we …

Continue reading

Averica Answers – What is Averica’s Approach to Impurity Isolation?

In this video, Paul Lefebvre discusses Averica’s approach for targeted isolation of impurities.   The stability indicating method is the gold standard for figuring out what’s what.  That’s what the customer is using to identify and quantify all the impurities that they have.  What we do is we kind of squish everything together, process a lot of material really fast, and chop it up.  Then we take the pieces and we analyze them by the gold standard.  And, we see …

Continue reading

Averica Discovery Expands Capabilities and Capacity by 50%

Enhances ability to supply early drug development programs while shorteningproject timelines MARLBOROUGH, MA, June 2, 2016 – Averica Discovery Services Inc., an analytical development contract research organization (CRO), today announced new hires and the acquisition of new equipment that significantly expands the Company’s capacity and capability.  Averica offers analytical development services to pharmaceutical companies; supporting new drug profiling, early to mid-stage clinical development, and CMC. Averica filled three new laboratory positions, and added new instrument systems: a new preparative Supercritical Fluid …

Continue reading

Averica Answers – Can You Tell Me About Your Free Chiral Screening?

In this video, Mickey Rego discusses Averica’s free chiral screening aspect of the chiral separation service. Here at Averica, one of our core service offerings is chiral purification.  Which is where our company really got its start, using the service to help support medicinal chemistry efforts.  We’ve expanded from there, and still pride ourselves on our ability to be an industry leader in the chiral separations field. Free chiral screening is a great tool used to derisk a separation project …

Continue reading

5 Ways to Prevent Impurity Isolation Scope Creep

Contracting tough projects with a CRO always requires active management, but some projects are complex enough that scope creep is a common problem.  Impurity isolation falls into this category – the target impurity is an unknown, present at an uncertain level in a sample, and may not be stable.  It’s a fun problem for the analytical team, but a headache for a project manager. Here are five tips on controlling scope creep in impurity isolation projects:   1)   Start …

Continue reading

Life Science Marketing Radio Interviews Olga Torres

In an inherently highly technical and highly customized contract research space, Olga Torres, Director of Marketing at Averica, developed a marketing plan that very successfully engages people based on Averica’s online presence.  In the Life Science Marketing Radio interview, Olga shares the importance of marketing for a niche life science business and lessons learned along the way to digital credibility. Click to link to podcast page, containing audio and transcript.   Life Science Marketing Radio, hosted …

Continue reading

Averica Answers – What Percent Recovery Can I Expect?

In this video, Jeff Kiplinger discusses the factors that can influence recovery when using chromatography for purification. Well, we’d like to be able to give everyone 100% of the material they sent in back.  The problem is when we receive compounds we receive compounds of different qualities.  The purity of the material that you send in can have an impact on how much you actually recover. For example, if you sent a salt form and we sent back a free …

Continue reading

Averica Answers – What Is Scalable Separation?

“What is Scalable Separation” briefly describes what  we mean when we talk about scalable separation. When we say scalable separations.  What we mean is that we develop each separation method so that it is scalable.  In other words, if you start with 100mg of compound that you need purified for some preliminary testing work – we can take that same separation method to 1g, 10g, 100g’s for advanced testing work.  So when I say scalable separation, what I mean is …

Continue reading